All In MedTech

Device Trial Radar · NCT06388629

Epicardial Access Study With Rook

Epicardial Access Study With Rook (EASY-R)

Last checked: Nov 20, 2026Latest source record: Aug 21, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

40

Planned (sponsor's estimate)

Start

Dec 17, 2023

Primary completion

Oct 15, 2024

Study completion Oct 15, 2024

Sponsor

Lead sponsor
Circa Scientific, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Apr 29, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The goal of this clinical trial is to test how how effective the Circa Scientific Rook® Epicardial Access Kit is at gaining guidewire access to the outside surface of the heart (epicardium). In addition the safety of the device will be compared to the available data for alternative methods of epicardial access. Participants will receive treatment with the subject device during the course of a typical epicardial electrophysiology procedure.

Conditions

  • Arrythmia

Interventions

  • Rook Epicardial Access KitDevice

    Access the epicardial surface of the heart via a subxiphoid approach with the subject device to facilitate guidewire placement into the pericardium.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Successful Epicardial AccessTime frame: During procedure.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Na Homolce Hospital

    Prague, Czechia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.